BIOMAT Database Logo BIOMAT Database Logo

beta-cell adaptation to hyperglycemia. 2001

R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
Joslin Diabetes Center, Boston, Massachusetts 02215, USA. ross.laybutt@joslin.harvard.edu

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D010180 Pancreatectomy Surgical removal of the pancreas. (Dorland, 28th ed) Pancreatectomies
D010695 Phlorhizin Phloridzin,Phlorizin
D002334 Carnitine O-Palmitoyltransferase An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21. Carnitine Palmitoyltransferase,CPT II,Carnitine Acyltransferase I,Carnitine Palmitoyltransferase I,Carnitine Palmitoyltransferase II,Palmitoylcarnitine Transferase,Palmitylcarnitine Acyltransferase,Acyltransferase I, Carnitine,Acyltransferase, Palmitylcarnitine,Carnitine O Palmitoyltransferase,II, Carnitine Palmitoyltransferase,O-Palmitoyltransferase, Carnitine,Palmitoyltransferase I, Carnitine,Palmitoyltransferase II, Carnitine,Palmitoyltransferase, Carnitine,Transferase, Palmitoylcarnitine
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000222 Adaptation, Physiological The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT. Adaptation, Physiologic,Adaptations, Physiologic,Adaptations, Physiological,Adaptive Plasticity,Phenotypic Plasticity,Physiological Adaptation,Physiologic Adaptation,Physiologic Adaptations,Physiological Adaptations,Plasticity, Adaptive,Plasticity, Phenotypic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
Hyperglycemia and beta-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man.
October 1983, Diabetes,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.
April 2008, Diabetes,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
Hyperglycemia alters the beta-cell sensitivity to beta-endorphin in noninsulin-dependent diabetic subjects.
May 1988, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
beta-cell neogenesis during prolonged hyperglycemia in rats.
June 2002, Diabetes,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
Chronic hyperglycemia and the human fetal beta cell.
November 1993, Pancreas,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
Beta-Cell Adaptation to Pregnancy - Role of Calcium Dynamics.
January 2022, Frontiers in endocrinology,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
Functional response of a limited beta-cell mass to long-term hyperglycemia.
March 1994, Pancreas,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
FOXO activity adaptation safeguards the hematopoietic stem cell compartment in hyperglycemia.
November 2020, Blood advances,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
Beta cell adaptation to pregnancy requires prolactin action on both beta and non-beta cells.
May 2021, Scientific reports,
R Laybutt, and W Hasenkamp, and A Groff, and S Grey, and J C Jonas, and H Kaneto, and A Sharma, and S Bonner-Weir, and G Weir
Beta cell adaptation in pregnancy: a tribute to Claes Hellerström.
May 2016, Upsala journal of medical sciences,
Copied contents to your clipboard!